학술논문

Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
Document Type
Article
Source
In The Lancet Oncology November 2015 16(15):1515-1524
Subject
Primary Research
Articles
Language
ISSN
1470-2045